← Back to Search

Simultaneous PET/MR Imaging for Brain Diseases

N/A

Waitlist Available

Research Sponsored by Stanford University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Whole body radiation dose within the last year of less than 5000 mrem

Subjects will be at least 21 years of age

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 24 months

Awards & highlights

Study Summary

This trial will study whether a brain-dedicated PET insert for an MR scanner can take PET/MR images of human brains simultaneously and compare its performance to a commercial PET/MRI system.

Who is the study for?

This trial is for healthy adults over 21 who haven't been exposed to high levels of radiation in the past year and are willing to undergo an injection with a small amount of radiotracer. They must not have cancer, be pregnant or nursing, or have metallic implants that would interfere with MRI.Check my eligibility

What is being tested?

Researchers are testing a new brain-dedicated PET insert designed for MR scanners by comparing it with existing PET/MRI systems. Participants will receive injections of FDA-approved tracers like FDG or Neuraceq to capture simultaneous PET/MR images of their brains.See study design

What are the potential side effects?

Potential side effects from the injected radiotracers may include allergic reactions, although both FDG and Neuraceq are generally well-tolerated since they're FDA approved. The study doesn't specify other side effects but standard risks apply as with any imaging agents.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have received less than 5000 mrem of radiation in the past year.

Select...

I am at least 21 years old.

Select...

I am willing to receive an injection of a tracer for my study.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 24 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 24 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

PETMR image

Trial Design

2Treatment groups

Experimental Treatment

Group I: Arm-2Experimental Treatment1 Intervention

20 participants will be recruited from other imaging studies that have been already injected (pre-injected) with a radiopharmaceutical. These subjects wont receive an additional injection of radiopharmaceutical.

Group II: Arm-1Experimental Treatment1 Intervention

20 participants will be recruited, inject with radiopharmaceutical, and imaged on the 3T PETMR with PET insert.

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor

2,387 Previous Clinical Trials

17,334,010 Total Patients Enrolled

8 Trials studying Brain Diseases

1,517 Patients Enrolled for Brain Diseases

Media Library

Pre-injected group with PET insert Clinical Trial Eligibility Overview. Trial Name: NCT04383808 — N/A

Brain Diseases Research Study Groups: Arm-2, Arm-1

Brain Diseases Clinical Trial 2023: Pre-injected group with PET insert Highlights & Side Effects. Trial Name: NCT04383808 — N/A

Pre-injected group with PET insert 2023 Treatment Timeline for Medical Study. Trial Name: NCT04383808 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this particular research initiative currently accepting candidates?

"This medical research, which was published on December 1st 2022, is no longer recruiting participants. However, there are 140 other trials currently accepting volunteers."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Clinical Translation of a Novel Brain PET Insert for Simultaneous PET/MR

Craig Levin 2022. "Clinical Translation of a Novel Brain PET Insert for Simultaneous PET/MR". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04383808.